Retension Pharmaceuticals, Inc. (RTSN)
Purchase of 30,800 shares across 2 reporting persons.
Transaction Code P · Reporting Persons 2
- BERGER FRANKLIN MPurchase of 10,000 shares at $12.00 per share.$120,000.00
- Keller Eric L., CHIEF EXECUTIVE OFFICERPurchase of 20,800 shares at $12.00 per share.$249,600.00
Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.
Traded Oct 13, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001213900-26-109155 · filed 2026-10-13 · View filing →
Source: SEC Form 4 · 0001213900-26-109160 · filed 2026-10-13 · View filing →